Michael Lee Milligan serves as Executive at Neumora Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Lee Milligan has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 8, 2026 involved receiving (via award) 350,000 shares valued at $0.
Michael Lee Milligan currently holds 350,000 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Lee Milligan has been a net neutral trader of NMRA stock. They have purchased $0 and sold $0 worth of shares.
Michael Lee Milligan's most recent insider trade was on Jan 8, 2026, when they sold 350,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |